Abstract:Objective To explore the feasibility of differentiation of bone marrow mesenchymal stem cells (MSCs) into epidermal cells under the microenvironment of diabetic wound. Methods MSCs were isolated from the myeloid tissue of the rats, purified and cultured. Third-or fourth-generation MSCs were selected and labelled with 5 - bromodeoxyuridine (5-BrdU). The rats were injected intraperitoneally with streptozocin(STZ) once to establish diabetes rat model. After 2 weeks, a round skin was excised on all dorsal back of rats. BrdU-labelled MSCs were, by means of injection, engrafted to skin of the rats. The specimens were harvested from the wound tissues for paraffin embedding and serial section at the 2nd and 3rd week after transplantation and were immunohistochemically stained by either BrdU or keratin. Results BrdU positive cells aggregated in the epidermis, dermis and hypodermia. In serial section, some positive cells expressed keratin simultaneously in the epidermis. Conclusion During the course of the diabetic wound healing, MSCs have the potential for differentiating into epidermal cells.

Preliminary study on differentiation of bone marrow mesenchymal stem cells into epidermal cells in diabetic wound